|
2024-02-06
|
R-HSA-9860276
|
SLC15A4:TASL-dependent IRF5 activation
|
BibTex
|
|
2023-05-24
|
R-HSA-9820952
|
Respiratory Syncytial Virus Infection Pathway
|
BibTex
|
|
2023-05-24
|
R-HSA-9820960
|
Respiratory syncytial virus (RSV) attachment and entry
|
BibTex
|
|
2023-02-10
|
R-HSA-9828211
|
Regulation of TBK1, IKK?-mediated activation of IRF3, IRF7 upon TLR3 ligation
|
BibTex
|
|
2023-01-23
|
R-HSA-9824856
|
Defective regulation of TLR7 by endogenous ligand
|
BibTex
|
|
2023-01-10
|
R-HSA-9824878
|
Regulation of TBK1, IKK? (IKBKE)-mediated activation of IRF3, IRF7
|
BibTex
|
|
2023-01-07
|
R-HSA-9823587
|
Defects of platelet adhesion to exposed collagen
|
BibTex
|
|
2023-01-07
|
R-HSA-9846298
|
Defective binding of VWF variant to GPIb:IX:V
|
BibTex
|
|
2023-01-07
|
R-HSA-9845619
|
Enhanced cleavage of VWF variant by ADAMTS13
|
BibTex
|
|
2023-01-07
|
R-HSA-9845622
|
Defective VWF binding to collagen type I
|
BibTex
|
|
2023-01-07
|
R-HSA-9845620
|
Enhanced binding of GP1BA variant to VWF multimer:collagen
|
BibTex
|
|
2023-01-07
|
R-HSA-9845621
|
Defective VWF cleavage by ADAMTS13 variant
|
BibTex
|
|
2021-11-12
|
R-HSA-9758274
|
Regulation of NF-kappa B signaling
|
BibTex
|
|
2021-10-27
|
R-HSA-9705683
|
SARS-CoV-2-host interactions
|
BibTex
|
|
2021-10-27
|
R-HSA-9705677
|
SARS-CoV-2 targets PDZ proteins in cell-cell junction
|
BibTex
|
|
2021-10-27
|
R-HSA-9755779
|
SARS-CoV-2 targets host intracellular signalling and regulatory pathways
|
BibTex
|
|
2021-10-27
|
R-HSA-9754560
|
SARS-CoV-2 modulates autophagy
|
BibTex
|
|
2021-10-27
|
R-HSA-9705671
|
SARS-CoV-2 activates/modulates innate and adaptive immune responses
|
BibTex
|
|
2021-10-27
|
R-HSA-9754678
|
SARS-CoV-2 modulates host translation machinery
|
BibTex
|
|
2020-11-09
|
R-HSA-9710421
|
Defective pyroptosis
|
BibTex
|
|
2020-11-09
|
R-HSA-5620971
|
Pyroptosis
|
BibTex
|
|
2020-07-08
|
R-HSA-9693928
|
Defective RIPK1-mediated regulated necrosis
|
BibTex
|
|
2020-06-25
|
R-HSA-9692914
|
SARS-CoV-1-host interactions
|
BibTex
|
|
2020-06-25
|
R-HSA-9735871
|
SARS-CoV-1 targets host intracellular signalling and regulatory pathways
|
BibTex
|
|
2020-06-25
|
R-HSA-9735869
|
SARS-CoV-1 modulates host translation machinery
|
BibTex
|
|
2020-06-25
|
R-HSA-9692916
|
SARS-CoV-1 activates/modulates innate immune responses
|
BibTex
|
|
2020-06-25
|
R-HSA-9692912
|
SARS-CoV-1 targets PDZ proteins in cell-cell junction
|
BibTex
|
|
2020-06-25
|
R-HSA-9692913
|
SARS-CoV-1-mediated effects on programmed cell death
|
BibTex
|
|
2020-05-21
|
R-HSA-9686347
|
Microbial modulation of RIPK1-mediated regulated necrosis
|
BibTex
|
|
2019-09-09
|
R-HSA-9671793
|
Diseases of hemostasis
|
BibTex
|
|
2019-09-09
|
R-HSA-9651496
|
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)
|
BibTex
|
|
2019-09-09
|
R-HSA-9672383
|
Defective factor IX causes thrombophilia
|
BibTex
|
|
2019-09-09
|
R-HSA-9657688
|
Defective factor XII causes hereditary angioedema
|
BibTex
|
|
2019-09-09
|
R-HSA-9657689
|
Defective SERPING1 causes hereditary angioedema
|
BibTex
|
|
2019-09-09
|
R-HSA-9668250
|
Defective factor IX causes hemophilia B
|
BibTex
|
|
2019-09-09
|
R-HSA-9673240
|
Defective gamma-carboxylation of F9
|
BibTex
|
|
2019-09-09
|
R-HSA-9673221
|
Defective F9 activation
|
BibTex
|
|
2019-09-09
|
R-HSA-9673202
|
Defective F9 variant does not activate FX
|
BibTex
|
|
2019-09-09
|
R-HSA-9673218
|
Defective F9 secretion
|
BibTex
|
|
2019-09-09
|
R-HSA-9662001
|
Defective factor VIII causes hemophilia A
|
BibTex
|
|
2019-09-09
|
R-HSA-9672396
|
Defective cofactor function of FVIIIa variant
|
BibTex
|
|
2019-09-09
|
R-HSA-9672397
|
Defective F8 secretion
|
BibTex
|
|
2019-09-09
|
R-HSA-9672393
|
Defective F8 binding to von Willebrand factor
|
BibTex
|
|
2019-09-09
|
R-HSA-9672395
|
Defective F8 binding to the cell membrane
|
BibTex
|
|
2019-09-09
|
R-HSA-9672391
|
Defective F8 cleavage by thrombin
|
BibTex
|
|
2019-09-09
|
R-HSA-9674519
|
Defective F8 sulfation at Y1699
|
BibTex
|
|
2019-09-09
|
R-HSA-9672387
|
Defective F8 accelerates dissociation of the A2 domain
|
BibTex
|
|
2019-05-17
|
R-HSA-9645460
|
Alpha-protein kinase 1 signaling pathway
|
BibTex
|
|
2018-10-23
|
R-HSA-8941413
|
Events associated with phagocytolytic activity of PMN cells
|
BibTex
|
|
2018-01-19
|
R-HSA-9024446
|
NR1H2 and NR1H3-mediated signaling
|
BibTex
|
|
2018-01-19
|
R-HSA-9029558
|
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
|
BibTex
|
|
2018-01-19
|
R-HSA-9632974
|
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis
|
BibTex
|
|
2018-01-19
|
R-HSA-9031525
|
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake
|
BibTex
|
|
2018-01-19
|
R-HSA-9031528
|
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose
|
BibTex
|
|
2018-01-19
|
R-HSA-9029569
|
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
|
BibTex
|
|
2018-01-19
|
R-HSA-9623433
|
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
|
BibTex
|
|
2017-07-26
|
R-HSA-9627069
|
Regulation of the apoptosome activity
|
BibTex
|
|
2017-07-26
|
R-HSA-111471
|
Apoptotic factor-mediated response
|
BibTex
|
|
2017-03-27
|
R-HSA-8983711
|
OAS antiviral response
|
BibTex
|
|
2016-11-19
|
R-HSA-3371497
|
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
|
BibTex
|
|
2015-10-05
|
R-HSA-6803157
|
Antimicrobial peptides
|
BibTex
|
|
2015-10-05
|
R-HSA-6799990
|
Metal sequestration by antimicrobial proteins
|
BibTex
|
|
2015-10-05
|
R-HSA-6803544
|
Ion influx/efflux at host-pathogen interface
|
BibTex
|
|
2015-09-12
|
R-HSA-5686938
|
Regulation of TLR by endogenous ligand
|
BibTex
|
|
2015-05-13
|
R-HSA-5684264
|
MAP3K8 (TPL2)-dependent MAPK1/3 activation
|
BibTex
|
|
2015-05-12
|
R-HSA-5626978
|
TNFR1-mediated ceramide production
|
BibTex
|
|
2015-05-12
|
R-HSA-5357956
|
TNFR1-induced NF-kappa-B signaling pathway
|
BibTex
|
|
2015-05-12
|
R-HSA-5357905
|
Regulation of TNFR1 signaling
|
BibTex
|
|
2015-02-10
|
R-HSA-5675482
|
Regulation of necroptotic cell death
|
BibTex
|
|
2014-12-17
|
R-HSA-5357786
|
TNFR1-induced proapoptotic signaling
|
BibTex
|
|
2014-11-18
|
R-HSA-5357801
|
Programmed Cell Death
|
BibTex
|
|
2014-05-21
|
R-HSA-5260271
|
Diseases of Immune System
|
BibTex
|
|
2014-05-21
|
R-HSA-5602358
|
Diseases associated with the TLR signaling cascade
|
BibTex
|
|
2014-05-21
|
R-HSA-5602410
|
TLR3 deficiency - HSE
|
BibTex
|
|
2014-05-21
|
R-HSA-5602571
|
TRAF3 deficiency - HSE
|
BibTex
|
|
2014-05-21
|
R-HSA-5602680
|
MyD88 deficiency (TLR5)
|
BibTex
|
|
2014-05-21
|
R-HSA-5602415
|
UNC93B1 deficiency - HSE
|
BibTex
|
|
2014-05-21
|
R-HSA-5602636
|
IKBKB deficiency causes SCID
|
BibTex
|
|
2014-05-21
|
R-HSA-5603037
|
IRAK4 deficiency (TLR5)
|
BibTex
|
|
2014-05-21
|
R-HSA-5602498
|
MyD88 deficiency (TLR2/4)
|
BibTex
|
|
2014-05-21
|
R-HSA-5603027
|
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
|
BibTex
|
|
2014-05-21
|
R-HSA-5603041
|
IRAK4 deficiency (TLR2/4)
|
BibTex
|
|
2014-05-21
|
R-HSA-5602566
|
TICAM1 deficiency - HSE
|
BibTex
|
|
2014-05-21
|
R-HSA-5603029
|
IkBA variant leads to EDA-ID
|
BibTex
|
|
2014-03-26
|
R-HSA-5357769
|
Caspase activation via extrinsic apoptotic signalling pathway
|
BibTex
|
|
2013-12-20
|
R-HSA-5218859
|
Regulated Necrosis
|
BibTex
|
|
2013-12-20
|
R-HSA-5213460
|
RIPK1-mediated regulated necrosis
|
BibTex
|
|
2013-12-20
|
R-HSA-5218900
|
CASP8 activity is inhibited
|
BibTex
|
|
2013-10-29
|
R-HSA-3371556
|
Cellular response to heat stress
|
BibTex
|
|
2013-10-29
|
R-HSA-3371453
|
Regulation of HSF1-mediated heat shock response
|
BibTex
|
|
2013-10-29
|
R-HSA-3371511
|
HSF1 activation
|
BibTex
|
|
2013-10-29
|
R-HSA-3371571
|
HSF1-dependent transactivation
|
BibTex
|
|
2013-10-29
|
R-HSA-3371568
|
Attenuation phase
|
BibTex
|
|
2013-05-13
|
R-HSA-3371378
|
Regulation by c-FLIP
|
BibTex
|
|
2013-04-10
|
R-HSA-3270619
|
IRF3-mediated induction of type I IFN
|
BibTex
|
|
2013-02-06
|
R-HSA-3134975
|
Regulation of innate immune responses to cytosolic DNA
|
BibTex
|
|
2013-02-06
|
R-HSA-3248023
|
Regulation by TREX1
|
BibTex
|
|
2013-02-06
|
R-HSA-3134963
|
DEx/H-box helicases activate type I IFN and inflammatory cytokines production
|
BibTex
|
|
2013-02-06
|
R-HSA-3249367
|
STAT6-mediated induction of chemokines
|
BibTex
|
|
2013-02-06
|
R-HSA-3134973
|
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
|
BibTex
|
|
2012-12-20
|
R-GGA-2132285
|
Complement Cascade
|
BibTex
|
|
2012-12-20
|
R-GGA-2132287
|
Creation of alternative pathway C3 convertase
|
BibTex
|
|
2012-12-20
|
R-GGA-2132293
|
Formation of fluid-phase convertase C3
|
BibTex
|
|
2012-12-20
|
R-GGA-2132273
|
Formation of membrane-bound convertase C3
|
BibTex
|
|
2012-12-20
|
R-GGA-2173345
|
Anaphylatoxins initiate inflammatory responses
|
BibTex
|
|
2012-12-20
|
R-GGA-2132270
|
Lectin-mediated initiation of complement cascade
|
BibTex
|
|
2012-12-20
|
R-GGA-2132286
|
Classical antibody-mediated complement activation
|
BibTex
|
|
2012-12-20
|
R-GGA-2132263
|
Creation of classical C3 convertase
|
BibTex
|
|
2012-12-20
|
R-GGA-2132281
|
Regulation of complement cascades
|
BibTex
|
|
2012-12-20
|
R-GGA-2132267
|
Formation of membrane attack complex (MAC)
|
BibTex
|
|
2012-10-17
|
R-HSA-2855086
|
Ficolins bind to repetitive carbohydrate structures on the target cell surface
|
BibTex
|
|
2012-07-09
|
R-HSA-1834941
|
STING mediated induction of host immune responses
|
BibTex
|
|
2012-06-07
|
R-GGA-2422406
|
Innate Immune System
|
BibTex
|
|
2012-05-15
|
R-HSA-9013957
|
TLR3-mediated TICAM1-dependent programmed cell death
|
BibTex
|
|
2012-05-15
|
R-HSA-2562578
|
TRIF-mediated programmed cell death
|
BibTex
|
|
2011-10-19
|
R-HSA-1679131
|
Trafficking and processing of endosomal TLR
|
BibTex
|
|
2011-09-21
|
R-HSA-1834949
|
Cytosolic sensors of pathogen-associated DNA
|
BibTex
|
|
2011-09-21
|
R-HSA-1606322
|
ZBP1(DAI) mediated induction of type I IFNs
|
BibTex
|
|
2011-09-21
|
R-HSA-1810476
|
RIP-mediated NFkB activation via ZBP1
|
BibTex
|
|
2011-09-21
|
R-HSA-1606341
|
IRF3 mediated activation of type 1 IFN
|
BibTex
|
|
2011-01-05
|
R-GGA-1227887
|
RLR (RIG-like receptor) mediated induction of IFN alpha/beta
|
BibTex
|
|
2011-01-05
|
R-GGA-1227739
|
Caspase-8 and -10 mediated induction of NF-kB
|
BibTex
|
|
2011-01-05
|
R-GGA-1227882
|
TRAF mediated activation of IRF
|
BibTex
|
|
2011-01-05
|
R-GGA-1227892
|
TRAF6 mediated NF-kB activation
|
BibTex
|
|
2011-01-05
|
R-GGA-1227888
|
Negative Regulation of MDA5 signaling
|
BibTex
|
|
2010-11-30
|
R-GGA-451529
|
TLR15 cascade
|
BibTex
|
|
2010-11-30
|
R-GGA-451531
|
TLR21 cascade
|
BibTex
|
|
2010-11-30
|
R-GGA-451477
|
MyD88-dependent cascade initiated on endosome membrane
|
BibTex
|
|
2010-11-30
|
R-GGA-573298
|
NFkB and MAPK activation mediated by TRAF6 upon TLR7 or TLR21 stimulation
|
BibTex
|
|
2010-11-30
|
R-GGA-977240
|
MyD88 cascade initiated on plasma membrane
|
BibTex
|
|
2010-10-06
|
R-HSA-975871
|
MyD88 cascade initiated on plasma membrane
|
BibTex
|
|
2010-08-25
|
R-HSA-975138
|
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
|
BibTex
|
|
2010-08-25
|
R-HSA-975110
|
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
|
BibTex
|
|
2010-06-01
|
R-HSA-9014325
|
TICAM1,TRAF6-dependent induction of TAK1 complex
|
BibTex
|
|
2010-06-01
|
R-HSA-9013973
|
TICAM1-dependent activation of IRF3/IRF7
|
BibTex
|
|
2010-06-01
|
R-HSA-975144
|
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
|
BibTex
|
|
2010-06-01
|
R-HSA-975163
|
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
|
BibTex
|
|
2010-06-01
|
R-HSA-937061
|
TRIF (TICAM1)-mediated TLR4 signaling
|
BibTex
|
|
2010-06-01
|
R-HSA-937041
|
IKK complex recruitment mediated by RIP1
|
BibTex
|
|
2010-06-01
|
R-HSA-937072
|
TRAF6-mediated induction of TAK1 complex within TLR4 complex
|
BibTex
|
|
2010-06-01
|
R-HSA-936964
|
Activation of IRF3, IRF7 mediated by TBK1, IKK? (IKBKE)
|
BibTex
|
|
2010-06-01
|
R-HSA-937042
|
IRAK2 mediated activation of TAK1 complex
|
BibTex
|
|
2010-06-01
|
R-HSA-937039
|
IRAK1 recruits IKK complex
|
BibTex
|
|
2010-05-18
|
R-GGA-433794
|
TLR4 cascade
|
BibTex
|
|
2010-02-20
|
R-GGA-517856
|
TLR2 subfamily cascade
|
BibTex
|
|
2010-01-05
|
R-GGA-451514
|
MyD88:TIRAP-dependent cascade initiated on plasma membrane
|
BibTex
|
|
2010-01-05
|
R-GGA-451524
|
MAPK activation in TLR cascade
|
BibTex
|
|
2010-01-05
|
R-GGA-451498
|
TLR7 cascade
|
BibTex
|
|
2010-01-05
|
R-GGA-451534
|
TLR5 cascade
|
BibTex
|
|
2009-12-16
|
R-HSA-450294
|
MAP kinase activation
|
BibTex
|
|
2009-12-16
|
R-HSA-450282
|
MAPK targets/ Nuclear events mediated by MAP kinases
|
BibTex
|
|
2009-12-16
|
R-HSA-450341
|
Activation of the AP-1 family of transcription factors
|
BibTex
|
|
2009-12-16
|
R-HSA-450302
|
activated TAK1 mediates p38 MAPK activation
|
BibTex
|
|
2009-12-16
|
R-HSA-450321
|
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
|
BibTex
|
|
2009-12-16
|
R-HSA-445989
|
TAK1-dependent IKK and NF-kappa-B activation
|
BibTex
|
|
2009-11-11
|
R-GGA-437987
|
Toll-like receptors (TLR) cascades
|
BibTex
|
|
2009-09-29
|
R-GGA-434048
|
TLR3 cascade
|
BibTex
|
|
2009-09-22
|
R-GGA-437980
|
Activated TAK1 mediates p38 MAP kinase phosphorylation
|
BibTex
|
|
2009-09-22
|
R-GGA-437986
|
Activated TAK1 mediates Jun kinases (JNK) phosphorylation and activation
|
BibTex
|
|
2009-09-22
|
R-GGA-451478
|
ERK activation
|
BibTex
|
|
2009-08-27
|
R-GGA-433835
|
IKK related kinases bound to dsRNA:TLR3:TICAM1 activate IRF3
|
BibTex
|
|
2009-08-27
|
R-GGA-434136
|
Viral dsRNA:TLR3:TICAM1 Complex Activates TBK1
|
BibTex
|
|
2009-08-27
|
R-GGA-433819
|
Viral dsRNA:TLR3:TICAM1 Complex Activates IKBKE_CHICK
|
BibTex
|
|
2009-08-27
|
R-GGA-433871
|
TRAF6 mediated induction of proinflammatory cytokines
|
BibTex
|
|
2009-08-27
|
R-GGA-434131
|
NFkB activation mediated by RIP1 complexed with activated TLR3
|
BibTex
|
|
2009-08-27
|
R-GGA-433822
|
NFkB and MAPK activation mediated by TRAF6
|
BibTex
|
|
2009-08-27
|
R-GGA-434001
|
TAK1 activates NFkB by phosphorylation and activation of IKKs complex
|
BibTex
|
